======= GPCPD1 =======
== Gene Information ==
* **Official Symbol**: GPCPD1
* **Official Name**: glycerophosphocholine phosphodiesterase 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56261|56261]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NPB8|Q9NPB8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=GPCPD1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GPCPD1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/614124|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: May be involved in the negative regulation of skeletal muscle differentiation, independently of its glycerophosphocholine phosphodiesterase activity. {ECO:0000250}.
|GDPD|
|CBM 20|
|starch binding|
|glycerophosphocholine phosphodiesterase activity|
|glycerophospholipid catabolic process|
|phospholipid catabolic process|
|glycerolipid catabolic process|
|skeletal muscle tissue development|
|organophosphate catabolic process|
|skeletal muscle organ development|
|cellular lipid catabolic process|
|striated muscle tissue development|
|muscle organ development|
|muscle tissue development|
|lipid catabolic process|
|glycerophospholipid metabolic process|
|phospholipid metabolic process|
|glycerolipid metabolic process|
|muscle structure development|
|organophosphate metabolic process|
|cellular lipid metabolic process|
|lipid metabolic process|
|tissue development|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-3|
|[[:results:exp536|Vitamin-D3 40μM R08 exp536]]|-2.08|
|[[:results:exp469|CFI-400945 25μM R08 exp469]]|-1.99|
|[[:results:exp504|MK2206 4μM R08 exp504]]|-1.96|
|[[:results:exp516|Pyrazinamide 100μM R08 exp516]]|-1.92|
|[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|-1.92|
|[[:results:exp538|ZLN024 50μM R08 exp538]]|-1.89|
|[[:results:exp362|GSK-J4 1μM R07 exp362]]|-1.71|
|[[:results:exp30|Rapamycin 10μM R00 exp30]]|-1.7|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 16344
* **Expression level (log2 read counts)**: 5.59
{{:chemogenomics:nalm6 dist.png?nolink |}}